Qudesan - an oral drug that reduces tissue hypoxia and normalizing metabolism infarction.
Qudesan produced in the form of drops for oral administration: clear, yellowish-orange with a slight opalescent (15, 20, 25, 50, 60, 100 ml vials of the light-shielded glass stoppers, droppers, in a cardboard bundle one bottle).
active substance is ubidekarenon: 1 ml - 30 mg.
Auxiliary components: alpha tocopherol acetate, macrogol glitserilgidroksistearat (Cremophor RH-40), sodium benzoate, citric food acid, ascorbyl palmitate, purified water.
adult drug prescribed for the treatment (in combination therapy) and prevention of various cardiovascular diseases:
Children older than 1 year Qudesa
In addition, both adults and children older than 1 year Qudesan recommend taking to prevent and replenish coenzyme Q10 deficiency;athletes - to improve the adaptation ability of the organism to increased physical activity.
Qudesan strictly contraindicated in the following cases:
Qudesan should be used with caution in patients with arterial hypotension.
The drug is not recommended for pregnant or breastfeeding women due to a lack of use of safety data during these periods.
drug is taken orally during a meal in the morning one time a day.Pre-drops dissolved in a small amount of liquid at room temperature.
Recommended preventive / therapeutic doses depending on the patient's age:
Duration of Qudesan - 2-3 months.If necessary, your doctor may recommend undergo refresher courses.
Basically the drug is well tolerated, in rare cases, you experience the following side effects:
Ubidekarenon reduces the effectiveness of warfarin, may potentiate the effect of nitrates, enalapril, metoprolol and diltiazem.
Tricyclic antidepressants, beta-blockers (metoprolol, atenolol, propranolol), hypolipidemic drugs (statins and fibrates) in the case of simultaneous application ubidekarenona can reduce the concentration in the blood plasma.
Store at room temperature (15-25 ° C) out of the reach of children, protected from light and moisture.
Shelf life - 2 years.
Corinfar - selective calcium channel blocker with antianginal and antihypertensive effect. release form and composition dosage form - table...
Korilip - based combination therapies cocarboxylase, riboflavin and lipoic acid with a tonic effect. composition and the form Korilip release...
Korizaliya - homeopathic medicinal product used in the treatment of rhinitis. release form and composition Korizaliyu released in the form ...